5th Annual CAR-TCR Summit | September 10-13, Boston MA
Event Sep 10 - Sep 13, 2019
Seaport Hotel & World Trade Center
Boston, MA, USA
The CAR-TCR Summit remains at the forefront of the industry bringing you never-seen-before data from the movers and shakers in CAR and TCR therapy development including Adaptimmune, Endocyte, Celyad, Allogene and many more. Dedicated to discussing the next generation candidates beyond CD19, from solid tumor indications to autoimmune disorders, this meeting provides an in depth breakdown of the current strategies to optimize the durability, persistence and targeting of approved and novel therapies to reduce relapse rates and overcome toxicity. At the premier, end-to-end summit focused on early research through to commercialization, join the experts to discuss how to streamline process development and logistics supply chains for affordable and accessible CAR-TCR therapeutics. Take advantage of the unrivaled networking opportunities as we bring together over 1000 industry leaders developing CAR-TCR based therapies from across pharma, biotech, regulatory bodies, academia, solution and service providers.